BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang Y, Huo Z, Qi X, Zuo T, Wu Z. Copper-induced tumor cell death mechanisms and antitumor theragnostic applications of copper complexes. Nanomedicine (Lond) 2022. [PMID: 35060391 DOI: 10.2217/nnm-2021-0374] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Chu B, Hong Z, Zheng X. The core genes of cuproptosis assists in discerning prognostic and immunological traits of clear cell renal cell carcinoma. Front Oncol 2022;12:925411. [DOI: 10.3389/fonc.2022.925411] [Reference Citation Analysis]
2 Ni S, Hong J, Li W, Ye M, Li J. Construction of a cuproptosis-related lncRNA signature for predicting prognosis and immune landscape in osteosarcoma patients. Cancer Med 2022. [PMID: 36129020 DOI: 10.1002/cam4.5214] [Reference Citation Analysis]
3 Chen X, Hu G, Xiong L, Xu Q. Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma. Pathol Oncol Res 2022;28:1610558. [DOI: 10.3389/pore.2022.1610558] [Reference Citation Analysis]
4 Xin S, Mao J, Cui K, Li Q, Chen L, Li Q, Tu B, Liu X, Wang T, Wang S, Liu J, Song X, Song W. A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma. Front Mol Biosci 2022;9:974722. [DOI: 10.3389/fmolb.2022.974722] [Reference Citation Analysis]
5 Tang Y, Li Q, Zhang D, Ma Z, Yang J, Cui Y, Zhang A. Cuproptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of early-stage lung adenocarcinoma patients. Front Genet 2022;13:977156. [DOI: 10.3389/fgene.2022.977156] [Reference Citation Analysis]
6 Xu Y, Li H, Lan A, Wu Q, Tang Z, Shu D, Tan Z, Liu X, Liu Y, Liu S, Zheng M. Cuprotosis-Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer Patients. Journal of Oncology 2022;2022:1-15. [DOI: 10.1155/2022/2363043] [Reference Citation Analysis]
7 Yang X, Wang X, Sun X, Xiao M, Fan L, Su Y, Xue L, Luo S, Hou S, Wang H. Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma. Front Genet 2022;13:972899. [DOI: 10.3389/fgene.2022.972899] [Reference Citation Analysis]
8 Chen B, Zhou X, Yang L, Zhou H, Meng M, Zhang L, Li J. A Cuproptosis Activation Scoring model predicts neoplasm-immunity interactions and personalized treatments in glioma. Comput Biol Med 2022;148:105924. [PMID: 35964468 DOI: 10.1016/j.compbiomed.2022.105924] [Reference Citation Analysis]
9 Liu J, Lu Y, Dai Y, Shen Y, Zeng C, Liu X, Yu H, Deng J, Lu W. A comprehensive analysis and validation of cuproptosis-associated genes across cancers: Overall survival, the tumor microenvironment, stemness scores, and drug sensitivity. Front Genet 2022;13:939956. [DOI: 10.3389/fgene.2022.939956] [Reference Citation Analysis]
10 Dinev D, Popova KB, Zhivkova T, Dyakova L, Abudalleh A, Alexandrova R, Culita DC, Mocanu T, Maxim C, Marinescu G. Synthesis, structural characterization, and cytotoxic activity in tumor cells of Cu(II) and Co(II) complexes with o ‐vanillin amino acids Schiff bases. Applied Organom Chemis. [DOI: 10.1002/aoc.6862] [Reference Citation Analysis]
11 Tang S, Zhao L, Wu X, Wang Z, Cai L, Pan D, Li Y, Zhou Y, Shen Y. Identification of a Novel Cuproptosis-Related Gene Signature for Prognostic Implication in Head and Neck Squamous Carcinomas. Cancers 2022;14:3986. [DOI: 10.3390/cancers14163986] [Reference Citation Analysis]
12 Hu Q, Wang R, Ma H, Zhang Z, Xue Q. Cuproptosis predicts the risk and clinical outcomes of lung adenocarcinoma. Front Oncol 2022;12:922332. [DOI: 10.3389/fonc.2022.922332] [Reference Citation Analysis]
13 Zhang C, Zeng Y, Guo X, Shen H, Zhang J, Wang K, Ji M, Huang S. Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker. Front Genet 2022;13:923737. [DOI: 10.3389/fgene.2022.923737] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Song Q, Zhou R, Shu F, Fu W. Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer. Front Immunol 2022;13:958368. [DOI: 10.3389/fimmu.2022.958368] [Reference Citation Analysis]
15 Sha S, Si L, Wu X, Chen Y, Xiong H, Xu Y, Liu W, Mei H, Wang T, Li M. Prognostic analysis of cuproptosis-related gene in triple-negative breast cancer. Front Immunol 2022;13:922780. [DOI: 10.3389/fimmu.2022.922780] [Reference Citation Analysis]
16 Mo X, Hu D, Yang P, Li Y, Bashir S, Nai A, Ma F, Jia G, Xu M. A novel cuproptosis-related prognostic lncRNA signature and lncRNA MIR31HG/miR-193a-3p/TNFRSF21 regulatory axis in lung adenocarcinoma. Front Oncol 2022;12:927706. [DOI: 10.3389/fonc.2022.927706] [Reference Citation Analysis]
17 Kadkhoda J, Tarighatnia A, Tohidkia MR, Nader ND, Aghanejad A. Photothermal therapy-mediated autophagy in breast cancer treatment: Progress and trends. Life Sciences 2022;298:120499. [DOI: 10.1016/j.lfs.2022.120499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Mohebbi Jahromi Z, Asadi Z, Eigner V, Dusek M, Rastegari B. A new phenoxo-bridged dicopper Schiff base Complex: Synthesis, Crystal Structure, DNA/BSA Interaction, Cytotoxicity Assay and Catecholase Activity. Polyhedron 2022. [DOI: 10.1016/j.poly.2022.115891] [Reference Citation Analysis]